Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Prepaid Assets (2023 - 2026)

Contineum Therapeutics' Prepaid Assets history spans 4 years, with the latest figure at $6.6 million for Q1 2026.

  • Quarterly Prepaid Assets rose 366.01% to $6.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Mar 2026, up 366.01% year-over-year, with the annual reading at $5.0 million for FY2025, 208.42% up from the prior year.
  • Prepaid Assets came in at $6.6 million for Q1 2026, up from $5.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.6 million in Q1 2026 to a low of $1.2 million in Q3 2024.
  • The 4-year median for Prepaid Assets is $1.7 million (2024), against an average of $2.6 million.
  • Year-over-year, Prepaid Assets plummeted 35.29% in 2024 and then surged 366.01% in 2026.
  • Contineum Therapeutics' Prepaid Assets stood at $2.5 million in 2023, then plummeted by 35.29% to $1.6 million in 2024, then skyrocketed by 208.42% to $5.0 million in 2025, then skyrocketed by 32.16% to $6.6 million in 2026.
  • Per Business Quant, the three most recent readings for CTNM's Prepaid Assets are $6.6 million (Q1 2026), $5.0 million (Q4 2025), and $2.5 million (Q3 2025).